drugset / Trial / NCT01019265

A Study Comparing Norspan Patch and Oral Tramadol

NCT01019265

Phase 4 Completed 170 enrolled Mundipharma Korea Ltd
RandomizedParallel-groupOpen-labelSupportive care

Summary

This trial was designed for comparison and evaluation of the efficacy and safety of buprenorphine transdermal patch (Norspan® patch 5 mg, 10 mg and 20mg) against oral tramadol (Tridol® SR (slow release) tablet 100mg) in patients with moderate to severe pain due to osteoarthritis.

Timeline

Start
2008-03
Primary completion
2009-03
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 5 mg Other
Subject Buprenorphine Other / unclassified 10 mg Other
Subject Buprenorphine Other / unclassified 20 mg Other
Subject Tramadol Other / unclassified 100 mg Oral

Indications